Potential treatment option discovered for children with Ewing’s sarcoma
Combining two anti-tumor agents appears to increase the sensitivity of cancer cells to these drugs and seems to lead to more effective Ewing’s sarcoma treatment.
Combining two anti-tumor agents appears to increase the sensitivity of cancer cells to these drugs and seems to lead to more effective Ewing’s sarcoma treatment.
Mesenchymal chondrosarcoma remains classified among the more deadly cancer types.
This slideshow reviews zoledronic acid (Zometa), indicated for pain reduction associated with bone metastases, hypercalcemia of malignancy, and osteolytic lesions of multiple myeloma.
Inhibiting the protein Sirtuin1 could play a part in fighting Ewing sarcoma, a common bone cancer in adolescents and children.
Better understanding of the two distinct processes at the heart of the genetic abnormality driving Ewing sarcoma development could lead to new, more effective therapies.
The compound PRM-151 (PRM) has shown success in reducing progressive bone marrow fibrosis in patients with advanced myelofibrosis.
A shoulder surgical aid, known as the Spider Limb Positioner, was adapted successfully to conduct a left hip disarticulation on a patient with melanoma.
Researchers believe that a staple of Earth science research can be used in biomedical settings to predict the course of disease.
Researchers investigating the distribution of trace elements in the tissue of bone tumors found that tumor tissue contains higher concentrations of trace elements, which could be a starting point in the development of targeted therapies for bone cancer.
A new type of magnetic resonance imaging (MRI) scan, known as diffusion-weighted MRI, could improve care for myeloma and reduce reliance on bone marrow biopsies.